Source:http://linkedlifedata.com/resource/pubmed/id/16368689
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0037791,
umls-concept:C0205145,
umls-concept:C0597298,
umls-concept:C1412403,
umls-concept:C1514562,
umls-concept:C1514873,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C1707271,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221
|
pubmed:issue |
9
|
pubmed:dateCreated |
2006-2-27
|
pubmed:abstractText |
Ankyrins contain significant amino acid identity and are co-expressed in many cell types yet maintain unique functions in vivo. Recent studies have identified the highly divergent C-terminal domain in ankyrin-B as the key domain for driving ankyrin-B-specific functions in cardiomyocytes. Here we identify an intramolecular interaction between the C-terminal domain and the membrane-binding domain of ankyrin-B using pure proteins in solution and the yeast two-hybrid assay. Through extensive deletion and alanine-scanning mutagenesis we have mapped key residues for interaction in both domains. Amino acids (1597)EED(1599) located in the ankyrin-B C-terminal domain and amino acids Arg(37)/Arg(40) located in ANK repeat 1 are necessary for inter-domain interactions in yeast two-hybrid assays. Furthermore, conversion of amino acids EED(1597) to AAA(1597) leads to a loss of function in the localization of inositol 1,4,5-trisphosphate receptors in ankyrin-B mutant cardiomyocytes. Physical properties of the ankyrin-B C-terminal domain determined by circular dichroism spectroscopy and hydrodynamic parameters reveal it is unstructured and highly extended in solution. Similar structural studies performed on full-length 220-kDa ankyrin-B harboring alanine substitutions, (1597)AAA(1599), reveal a more extended conformation compared with wild-type ankyrin-B. Taken together these results suggest a model of an extended and unstructured C-terminal domain folding back to bind and potentially regulate the membrane-binding domain of ankyrin-B.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
281
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5741-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16368689-Amino Acid Sequence,
pubmed-meshheading:16368689-Animals,
pubmed-meshheading:16368689-Ankyrins,
pubmed-meshheading:16368689-Binding Sites,
pubmed-meshheading:16368689-Humans,
pubmed-meshheading:16368689-Mice,
pubmed-meshheading:16368689-Molecular Sequence Data,
pubmed-meshheading:16368689-Mutagenesis,
pubmed-meshheading:16368689-Myocytes, Cardiac,
pubmed-meshheading:16368689-Protein Conformation,
pubmed-meshheading:16368689-Protein Isoforms,
pubmed-meshheading:16368689-Protein Structure, Tertiary,
pubmed-meshheading:16368689-Recombinant Fusion Proteins,
pubmed-meshheading:16368689-Sequence Alignment,
pubmed-meshheading:16368689-Two-Hybrid System Techniques
|
pubmed:year |
2006
|
pubmed:articleTitle |
Isoform specificity of ankyrin-B: a site in the divergent C-terminal domain is required for intramolecular association.
|
pubmed:affiliation |
Howard Hughes Medical Institute, and Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|